Is it time to target no evident disease activity (NEDA) in multiple sclerosis?

The management of multiple sclerosis is becoming increasingly complex with the emergence of new and more effective disease-modifying therapies (DMT). We propose a new treatment paradigm that individualises treatment based on a choice between two interchangeable therapeutic strategies of maintenance-...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Multiple sclerosis and related disorders Jg. 4; H. 4; S. 329 - 333
Hauptverfasser:	Giovannoni, Gavin, Turner, Benjamin, Gnanapavan, Sharmilee, Offiah, Curtis, Schmierer, Klaus, Marta, Monica
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Netherlands Elsevier B.V 01.07.2015
Schlagworte:	Algorithms Disease activity free Disease modifying therapy Disease Progression Humans Magnetic Resonance Imaging Multiple sclerosis Multiple Sclerosis - pathology Multiple Sclerosis - physiopathology Multiple Sclerosis - therapy NEDA Neurology No evident disease activity Precision Medicine - methods Treating to target Treatment Outcome NEDA Disease modifying therapy Multiple sclerosis Disease activity free No evident disease activity Treating to target
ISSN:	2211-0348, 2211-0356, 2211-0356
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!